• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Introduction to 2-(Quinolin-4-yl)propanoic Acid (CAS No. 1539775-73-9)

2-(Quinolin-4-yl)propanoic acid, also known by its CAS number 1539775-73-9, is a versatile compound with significant potential in various fields of chemistry and pharmaceutical research. This article provides a comprehensive overview of the compound, including its chemical structure, physical properties, synthesis methods, and recent applications in drug development and biological studies.

The chemical structure of 2-(quinolin-4-yl)propanoic acid is characterized by a quinoline ring attached to a propanoic acid moiety. The quinoline ring, a heterocyclic aromatic compound, imparts unique chemical and biological properties to the molecule. The propanoic acid group, on the other hand, contributes to the compound's acidity and reactivity. This combination makes 2-(quinolin-4-yl)propanoic acid an interesting candidate for a wide range of applications.

In terms of physical properties, 2-(quinolin-4-yl)propanoic acid is typically a white crystalline solid with a melting point of around 160°C. It is slightly soluble in water but highly soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). These solubility characteristics are crucial for its use in various chemical reactions and biological assays.

The synthesis of 2-(quinolin-4-yl)propanoic acid can be achieved through several methods. One common approach involves the reaction of 4-bromoquinoline with propionic acid in the presence of a suitable catalyst. Another method involves the coupling of 4-bromoquinoline with propionyl chloride followed by hydrolysis to form the final product. These synthetic routes have been optimized to yield high purity and yield, making them suitable for large-scale production.

Recent research has highlighted the potential of 2-(quinolin-4-yl)propanoic acid in drug development and biological studies. For instance, studies have shown that this compound exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This makes it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory effects, 2-(quinolin-4-yl)propanoic acid has also been investigated for its potential as an anticancer agent. Research has demonstrated that it can induce apoptosis in cancer cells by modulating key signaling pathways involved in cell survival and proliferation. Specifically, it has been shown to inhibit the activation of the Akt/mTOR pathway, which is frequently dysregulated in various types of cancer.

The pharmacokinetic properties of 2-(quinolin-4-yl)propanoic acid have also been studied extensively. It has been found to have good oral bioavailability and a favorable pharmacokinetic profile, making it suitable for oral administration. Furthermore, it exhibits low toxicity in preclinical studies, which is an important consideration for its potential use as a therapeutic agent.

In conclusion, 2-(quinolin-4-yl)propanoic acid (CAS No. 1539775-73-9) is a promising compound with diverse applications in chemistry and pharmaceutical research. Its unique chemical structure and favorable physical properties make it an attractive candidate for further investigation and development. Ongoing research continues to uncover new potential uses for this compound, highlighting its significance in the field of medicinal chemistry.

• 1368259-54-4(2-(4-Methylquinolin-6-yl)acetic acid)
• 1700242-31-4(2-(Isoquinolin-8-yl)propanoic acid)
• 1511565-29-9(3-methyl-2-(quinolin-4-yl)butanoic acid)
• 1505201-95-5(2-(quinolin-4-yl)butanoic acid)
• 959585-30-9(2-(Quinolin-6-yl)propanoic acid)
• 1022283-51-7(2-Methyl-2-(quinolin-6-YL)propanoic acid)
• 52263-68-0(2-(9H-Carbazol-2-yl)propanoic acid)
• 109922-57-8(2-(Quinolin-4-yl)acetic acid)
• 1500548-32-2(2-(Quinolin-7-yl)propanoic acid)
• 581813-22-1(2-(Isoquinolin-5-yl)propanoic acid)